hotspot -WSS

hotspot

author：leisure time 2025-09-30 15:22:21 - browse：97753

Photograph of an abandoned lab with empty bottle, boxes, and beakers all around. -- biotech coverage from STAT — Adobe

SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company’s leadership believed they were poised for success — until everything slowly and irreversibly fell apart.

Three years later, Histogen no longer develops therapies. It has abandoned efforts to reverse baldness, replenish cartilage in achy knees, and quell infection and inflammation.

The company has no lab. It has no headquarters. It has just two employees, including a chief financial officer who also serves as secretary, CEO, and president. Histogen’s stock trades below $1 a share. And even that is coming to a close. On Thursday, the Nasdaq suspended trading of Histogen shares after determining that the company’s operations and assets are negligible, meaning the biotech is now officially a shell of its former self.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Protect nursing home residents from future pandemics

WSS

Structure Therapeutics oral GLP

Medical students need to learn the potent medicine of empathy

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Lawsuit challenges CMS nursing home minimum staffing rule

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Eli Lilly’s Zepbound improved liver scarring in mid

explore

hotspot

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

J&J reports mixed data on next

Medicare details structure of new drug price negotiation program

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Dobbs anniversary: the lost opportunity of abortion as health care

FDA approves Moderna’s RSV vaccine, its second licensed product

Dobbs anniversary: the lost opportunity of abortion as health care

Lawsuit challenges CMS nursing home minimum staffing rule

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Eli Lilly’s Zepbound improved liver scarring in mid

hotspot

Medicare Advantage's lean provider networks lead CMS complaints

Congress needs to close a vaccine

Structure Therapeutics oral GLP

Why some fertility treatments produce more boy babies

An outdated Medicare rule harms dementia patients with anxiety

Why some fertility treatments produce more boy babies

focus

explore

explore

explore